Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1989 1
1991 1
1992 1
1993 5
1994 3
1995 4
1996 2
1997 5
1998 3
1999 4
2000 4
2002 2
2003 1
2004 7
2005 6
2006 9
2007 4
2008 7
2009 15
2010 19
2011 12
2012 9
2013 15
2014 13
2015 12
2016 5
2017 7
2018 8
2019 22
2020 30
2021 21
2022 23
2023 19
2024 13
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Intracellular Edema.
Narayanan R, Kuppermann BD. Narayanan R, et al. Among authors: kuppermann bd. Dev Ophthalmol. 2017;58:21-26. doi: 10.1159/000455266. Epub 2017 Mar 28. Dev Ophthalmol. 2017. PMID: 28351042 Review.
Brolucizumab in polypoidal choroidal vasculopathy.
Sharma A, Parachuri N, Kumar N, Kuppermann BD, Loewenstein A, Bandello F. Sharma A, et al. Among authors: kuppermann bd. Expert Opin Biol Ther. 2022 Jul;22(7):809-812. doi: 10.1080/14712598.2022.2094239. Epub 2022 Jun 27. Expert Opin Biol Ther. 2022. PMID: 35737884 No abstract available.
Immune recovery uveitis.
Kuppermann BD, Holland GN. Kuppermann BD, et al. Am J Ophthalmol. 2000 Jul;130(1):103-6. doi: 10.1016/s0002-9394(00)00537-7. Am J Ophthalmol. 2000. PMID: 11004267 Review. No abstract available.
Brolucizumab: the road ahead.
Sharma A, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD. Sharma A, et al. Among authors: kuppermann bd. Br J Ophthalmol. 2020 Dec;104(12):1631-1632. doi: 10.1136/bjophthalmol-2020-317528. Epub 2020 Aug 22. Br J Ophthalmol. 2020. PMID: 32829303 No abstract available.
Brolucizumab and immunogenicity.
Sharma A, Kumar N, Parachuri N, Sharma R, Bandello F, Kuppermann BD, Loewenstein A. Sharma A, et al. Among authors: kuppermann bd. Eye (Lond). 2020 Oct;34(10):1726-1728. doi: 10.1038/s41433-020-0853-9. Epub 2020 Apr 6. Eye (Lond). 2020. PMID: 32251366 Free PMC article. No abstract available.
Immunogenicity: Clouding the Future of Intravitreal Therapy.
Sharma A, Kumar N, Parachuri N, Bandello F, Kuppermann BD. Sharma A, et al. Among authors: kuppermann bd. Ocul Immunol Inflamm. 2023 Nov;31(9):1746-1749. doi: 10.1080/09273948.2022.2139273. Epub 2022 Nov 4. Ocul Immunol Inflamm. 2023. PMID: 36332149 No abstract available.
Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern.
Prakash S, Dhanushkodi NR, Zayou L, Ibraim IC, Quadiri A, Coulon PG, Tifrea DF, Suzer B, Shaik AM, Chilukuri A, Edwards RA, Singer M, Vahed H, Nesburn AB, Kuppermann BD, Ulmer JB, Gil D, Jones TM, BenMohamed L. Prakash S, et al. Among authors: kuppermann bd. Front Immunol. 2024 Jan 22;15:1328905. doi: 10.3389/fimmu.2024.1328905. eCollection 2024. Front Immunol. 2024. PMID: 38318166 Free PMC article.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. Haller JA, et al. Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24. Ophthalmology. 2010. PMID: 20417567 Clinical Trial.
278 results